Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Merola

Showing results (241-250 of 394) with videos related to

Pageof 40
Sort By:
Dermatology Online Journal|June 5, 2026
Lichen planus autoimmune comorbidities: A retrospective case control studyAngela L Rosenberg, Alexander Wu, Lauren DeBusk, et al.
Rheumatology and Therapy|October 15, 2022
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 StudyIain B McInnes, Koji Kato, Marina Magrey, et al.
The British Journal of Dermatology|June 20, 2022
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: EpidemiologyMaria C Schneeweiss, Julien Kirchgesner, Richard Wyss, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual MeetingPhilip J Mease, Leonard H Calabrese, Kristina Callis Duffin, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Validation of claims-based algorithms to identify patients with psoriasisHemin Lee, Mengdong He, Soo-Kyung Cho, et al.
The British Journal of Dermatology|April 6, 2023
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposureMark G Lebwohl, Joseph F Merola, Katelyn Rowland, et al.
JAAD International|January 5, 2026
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort studyPriyanka Anand, Arash Mostaghimi, Robert Glynn, et al.
The Journal of Dermatological Treatment|May 26, 2018
Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severityMwangi J Murage, Amanda Anderson, Deborah Casso, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
Pageof 40

Showing results (241-250 of 394) with videos related to

Sort By:
Pageof 40
Dermatology Online Journal|June 5, 2026
Lichen planus autoimmune comorbidities: A retrospective case control studyAngela L Rosenberg, Alexander Wu, Lauren DeBusk, et al.
Rheumatology and Therapy|October 15, 2022
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 StudyIain B McInnes, Koji Kato, Marina Magrey, et al.
The British Journal of Dermatology|June 20, 2022
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: EpidemiologyMaria C Schneeweiss, Julien Kirchgesner, Richard Wyss, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual MeetingPhilip J Mease, Leonard H Calabrese, Kristina Callis Duffin, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Validation of claims-based algorithms to identify patients with psoriasisHemin Lee, Mengdong He, Soo-Kyung Cho, et al.
The British Journal of Dermatology|April 6, 2023
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposureMark G Lebwohl, Joseph F Merola, Katelyn Rowland, et al.
JAAD International|January 5, 2026
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort studyPriyanka Anand, Arash Mostaghimi, Robert Glynn, et al.
The Journal of Dermatological Treatment|May 26, 2018
Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severityMwangi J Murage, Amanda Anderson, Deborah Casso, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
Pageof 40